Corporate Actions

Back

Noumed Pharmaceuticals secures a three-year, Rs 204 crore OTC Medicines Supply Agreement with an Australian pharmacy chain

25-Aug-26 20:00 Hrs IST

Sai Parenterals Limited announced that its subsidiary, Noumed Pharmaceuticals Pty Limited, has renewed a long-term Over-the-Counter (OTC) Medicines Supply Agreement with a leading Australian pharmacy chain, featuring an expanded product portfolio and a three-year term. The renewed agreement is valued at AUD 30 million, which equates to approximately Rs 204 Crores based on an exchange rate of Rs 68.52 per AUD, and does not involve any related party transactions or interest from the company's promoters or group entities. The effective date of the agreement is August 24, 2026.

Attention Investors:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. || KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. || No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.